226 related articles for article (PubMed ID: 28182001)
1. RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer.
Hui K; Gao Y; Huang J; Xu S; Wang B; Zeng J; Fan J; Wang X; Yue Y; Wu S; Hsieh JT; He D; Wu K
Cell Death Dis; 2017 Feb; 8(2):e2600. PubMed ID: 28182001
[TBL] [Abstract][Full Text] [Related]
2. RASAL2 inhibits tumor angiogenesis via p-AKT/ETS1 signaling in bladder cancer.
Hui K; Wu S; Yue Y; Gu Y; Guan B; Wang X; Hsieh JT; Chang LS; He D; Wu K
Cell Signal; 2018 Aug; 48():38-44. PubMed ID: 29702203
[TBL] [Abstract][Full Text] [Related]
3. RASAL2 promotes lung cancer metastasis through epithelial-mesenchymal transition.
Li N; Li S
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):358-62. PubMed ID: 25446096
[TBL] [Abstract][Full Text] [Related]
4. RASAL2 down-regulation in ovarian cancer promotes epithelial-mesenchymal transition and metastasis.
Huang Y; Zhao M; Xu H; Wang K; Fu Z; Jiang Y; Yao Z
Oncotarget; 2014 Aug; 5(16):6734-45. PubMed ID: 25216515
[TBL] [Abstract][Full Text] [Related]
5. miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion.
Huang J; Wang B; Hui K; Zeng J; Fan J; Wang X; Hsieh JT; He D; Wu K
Oncol Rep; 2016 Sep; 36(3):1693-701. PubMed ID: 27430302
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
Huang SY; Chang SF; Liao KF; Chiu SC
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
[TBL] [Abstract][Full Text] [Related]
7. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
8. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
[TBL] [Abstract][Full Text] [Related]
9. Low Expression of Rasal2 Promotes Non-small Cell Lung Cancer Metastasis through Ras/ERK Pathway.
Fan D; Yu S; Yang Y; Qu S
Biol Pharm Bull; 2021; 44(7):992-998. PubMed ID: 34193694
[TBL] [Abstract][Full Text] [Related]
10. MiR-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop.
Xu M; Li J; Wang X; Meng S; Shen J; Wang S; Xu X; Xie B; Liu B; Xie L
Cell Death Dis; 2018 Feb; 9(2):209. PubMed ID: 29434190
[TBL] [Abstract][Full Text] [Related]
11. RASAL2 activates RAC1 to promote triple-negative breast cancer progression.
Feng M; Bao Y; Li Z; Li J; Gong M; Lam S; Wang J; Marzese DM; Donovan N; Tan EY; Hoon DS; Yu Q
J Clin Invest; 2014 Dec; 124(12):5291-304. PubMed ID: 25384218
[TBL] [Abstract][Full Text] [Related]
12. The SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancer.
Li Y; Lv Z; He G; Wang J; Zhang X; Lu G; Ren X; Wang F; Zhu X; Ding Y; Liao W; Ding Y; Liang L
Oncotarget; 2015 Apr; 6(11):9099-112. PubMed ID: 25868860
[TBL] [Abstract][Full Text] [Related]
13. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
[TBL] [Abstract][Full Text] [Related]
14. The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression.
Huang J; Lo UG; Wu S; Wang B; Pong RC; Lai CH; Lin H; He D; Hsieh JT; Wu K
Cell Death Dis; 2019 Jun; 10(6):437. PubMed ID: 31164632
[TBL] [Abstract][Full Text] [Related]
15. The RasGAP gene, RASAL2, is a tumor and metastasis suppressor.
McLaughlin SK; Olsen SN; Dake B; De Raedt T; Lim E; Bronson RT; Beroukhim R; Polyak K; Brown M; Kuperwasser C; Cichowski K
Cancer Cell; 2013 Sep; 24(3):365-78. PubMed ID: 24029233
[TBL] [Abstract][Full Text] [Related]
16. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
[TBL] [Abstract][Full Text] [Related]
17. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
[TBL] [Abstract][Full Text] [Related]
18. miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer.
Yan M; Li X; Tong D; Han C; Zhao R; He Y; Jin X
Oncol Rep; 2016 Jul; 36(1):65-71. PubMed ID: 27108696
[TBL] [Abstract][Full Text] [Related]
19. The expression and function of RASAL2 in renal cell carcinoma angiogenesis.
Hui K; Yue Y; Wu S; Gu Y; Guan B; Wang X; Hsieh JT; Chang LS; He D; Wu K
Cell Death Dis; 2018 Aug; 9(9):881. PubMed ID: 30158581
[TBL] [Abstract][Full Text] [Related]
20. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness.
Wu K; Ning Z; Zeng J; Fan J; Zhou J; Zhang T; Zhang L; Chen Y; Gao Y; Wang B; Guo P; Li L; Wang X; He D
Cell Signal; 2013 Dec; 25(12):2625-33. PubMed ID: 24012496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
